BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/20/2014 6:38:00 PM | Browse: 1309 | Download: 1243
 |
Received |
|
2013-11-14 07:36 |
 |
Peer-Review Started |
|
2013-11-14 14:59 |
 |
To Make the First Decision |
|
2014-01-09 15:38 |
 |
Return for Revision |
|
2014-01-17 17:29 |
 |
Revised |
|
2014-01-25 04:29 |
 |
Second Decision |
|
2014-04-03 10:16 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-04-03 12:34 |
 |
Articles in Press |
|
2014-05-23 09:54 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-08-06 15:55 |
 |
Publish the Manuscript Online |
|
2014-08-20 18:38 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Topic Highlights |
Article Title |
Recurrent hepatitis C after liver transplant
|
Manuscript Source |
Invited Manuscript |
All Author List |
Andrew S deLemos, Paul A Schmeltzer and Mark W Russo |
Funding Agency and Grant Number |
|
Corresponding Author |
Mark W Russo, MD, MPH, Department of Medicine, Center for Liver Diseases and Transplantation, Carolinas Medical Center, 1000 Blythe Blvd, Charlotte, NC 28232-2861, United States. mark.russo@carolinashealthcare.org |
Key Words |
Hepatitis C; Liver transplant; Donor risk factors; Immunosuppression; Protease inhibitors; Fibrosing cholestatic hepatitis C; Acute cellular rejection; Cytomegalovirus |
Core Tip |
Recurrent hepatitis C impacts graft and patient survival following liver transplant. Preventing aggressive hepatitis C virus (HCV) recurrence by selecting appropriate donor allografts for HCV patients and careful management of immunosuppression in the post-transplant setting remain crucial. Direct acting antiviral therapy in patients awaiting transplant may prevent HCV re-infection post-transplant and has the potential to fundamentally change the natural history of hepatitis C in liver transplant recipients. |
Publish Date |
2014-08-20 18:38 |
Citation |
deLemos AS, Schmeltzer PA, Russo MW. Recurrent hepatitis C after liver transplant. World J Gastroenterol 2014; 20(31): 10668-10681 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i31/10668.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i31.10668 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345